nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—AR—obesity	0.848	1	CbGaD
Oxandrolone—Epididymitis—Sibutramine—obesity	0.00647	0.0735	CcSEcCtD
Oxandrolone—Menstruation irregular—Orlistat—obesity	0.00355	0.0403	CcSEcCtD
Oxandrolone—Erectile dysfunction—Methamphetamine—obesity	0.00346	0.0393	CcSEcCtD
Oxandrolone—Gynaecomastia—Diethylpropion—obesity	0.00335	0.038	CcSEcCtD
Oxandrolone—Gynaecomastia—Cimetidine—obesity	0.00319	0.0362	CcSEcCtD
Oxandrolone—Irritability—Phenylpropanolamine—obesity	0.00311	0.0354	CcSEcCtD
Oxandrolone—Menstruation irregular—Bupropion—obesity	0.003	0.034	CcSEcCtD
Oxandrolone—Hirsutism—Bupropion—obesity	0.00285	0.0324	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—SHBG—obesity	0.00277	0.0508	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—KDM3A—obesity	0.0025	0.0459	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Phentermine—obesity	0.00249	0.0282	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—SFTPA2—obesity	0.00246	0.0452	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Cimetidine—obesity	0.00242	0.0275	CcSEcCtD
Oxandrolone—Acne—Orlistat—obesity	0.00234	0.0265	CcSEcCtD
Oxandrolone—Acne—Sibutramine—obesity	0.00226	0.0257	CcSEcCtD
Oxandrolone—Erectile dysfunction—Diethylpropion—obesity	0.00216	0.0246	CcSEcCtD
Oxandrolone—Erectile dysfunction—Cimetidine—obesity	0.00206	0.0234	CcSEcCtD
Oxandrolone—Creatinine increased—Sibutramine—obesity	0.002	0.0227	CcSEcCtD
Oxandrolone—Acne—Bupropion—obesity	0.00197	0.0224	CcSEcCtD
Oxandrolone—Insomnia—Methamphetamine—obesity	0.00193	0.0219	CcSEcCtD
Oxandrolone—Insomnia—Benzphetamine—obesity	0.00186	0.0212	CcSEcCtD
Oxandrolone—Fluid retention—Sibutramine—obesity	0.00181	0.0205	CcSEcCtD
Oxandrolone—Neoplasm—Orlistat—obesity	0.00178	0.0202	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—PPARD—obesity	0.00175	0.032	CbGpPWpGaD
Oxandrolone—Neoplasm—Sibutramine—obesity	0.00172	0.0195	CcSEcCtD
Oxandrolone—Insomnia—Phendimetrazine—obesity	0.0017	0.0193	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—NR1I3—obesity	0.00159	0.0292	CbGpPWpGaD
Oxandrolone—Oedema—Phentermine—obesity	0.00153	0.0174	CcSEcCtD
Oxandrolone—Neoplasm—Bupropion—obesity	0.0015	0.017	CcSEcCtD
Oxandrolone—Gynaecomastia—Bupropion—obesity	0.00148	0.0169	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—NR1I2—obesity	0.00146	0.0267	CbGpPWpGaD
Oxandrolone—Insomnia—Phenylpropanolamine—obesity	0.00145	0.0165	CcSEcCtD
Oxandrolone—Insomnia—Phentermine—obesity	0.00139	0.0158	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARD—obesity	0.00138	0.0253	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Sibutramine—obesity	0.00129	0.0147	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1I3—obesity	0.00126	0.0231	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR0B2—obesity	0.00126	0.0231	CbGpPWpGaD
Oxandrolone—Acne—Topiramate—obesity	0.00126	0.0143	CcSEcCtD
Oxandrolone—Insomnia—Diethylpropion—obesity	0.00121	0.0137	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—obesity	0.00116	0.0212	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR1I2—obesity	0.00115	0.0211	CbGpPWpGaD
Oxandrolone—Irritability—Bupropion—obesity	0.00115	0.0131	CcSEcCtD
Oxandrolone—Creatinine increased—Topiramate—obesity	0.00111	0.0126	CcSEcCtD
Oxandrolone—Erectile dysfunction—Sibutramine—obesity	0.0011	0.0125	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—MYOD1—obesity	0.00109	0.0201	CbGpPWpGaD
Oxandrolone—Fluid retention—Topiramate—obesity	0.001	0.0114	CcSEcCtD
Oxandrolone—Haemoglobin—Orlistat—obesity	0.000992	0.0113	CcSEcCtD
Oxandrolone—Haemorrhage—Orlistat—obesity	0.000987	0.0112	CcSEcCtD
Oxandrolone—Haemoglobin—Sibutramine—obesity	0.00096	0.0109	CcSEcCtD
Oxandrolone—Erectile dysfunction—Bupropion—obesity	0.000958	0.0109	CcSEcCtD
Oxandrolone—Haemorrhage—Sibutramine—obesity	0.000955	0.0109	CcSEcCtD
Oxandrolone—Neoplasm—Topiramate—obesity	0.000955	0.0109	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR2—obesity	0.000866	0.0159	CbGpPWpGaD
Oxandrolone—Haemoglobin—Bupropion—obesity	0.000837	0.00951	CcSEcCtD
Oxandrolone—Haemorrhage—Bupropion—obesity	0.000833	0.00946	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—NR0B2—obesity	0.000806	0.0148	CbGpPWpGaD
Oxandrolone—Stanozolol—AR—obesity	0.00079	0.0821	CrCbGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—PARP1—obesity	0.000771	0.0141	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—GCG—obesity	0.000744	0.0136	CbGpPWpGaD
Oxandrolone—Irritability—Topiramate—obesity	0.000732	0.00832	CcSEcCtD
Oxandrolone—Blood creatinine increased—Topiramate—obesity	0.000719	0.00816	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—obesity	0.000708	0.013	CbGpPWpGaD
Oxandrolone—Oedema—Orlistat—obesity	0.000701	0.00797	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR2—obesity	0.000684	0.0125	CbGpPWpGaD
Oxandrolone—Oedema—Sibutramine—obesity	0.000679	0.00771	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—NCOA1—obesity	0.000673	0.0123	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—FTL—obesity	0.000647	0.0119	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—ACADM—obesity	0.000638	0.0117	CbGpPWpGaD
Oxandrolone—Insomnia—Orlistat—obesity	0.000634	0.00721	CcSEcCtD
Oxandrolone—Trilostane—ESR2—obesity	0.00062	0.0644	CrCbGaD
Oxandrolone—AR—Nuclear Receptors—NR3C1—obesity	0.000618	0.0113	CbGpPWpGaD
Oxandrolone—Insomnia—Sibutramine—obesity	0.000614	0.00697	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—NCOA1—obesity	0.000611	0.0112	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—APOB—obesity	0.000611	0.0112	CbGpPWpGaD
Oxandrolone—Erectile dysfunction—Topiramate—obesity	0.000611	0.00694	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC9A3—obesity	0.000605	0.0111	CbGpPWpGaD
Oxandrolone—Oedema—Bupropion—obesity	0.000592	0.00672	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—PPARA—obesity	0.00058	0.0106	CbGpPWpGaD
Oxandrolone—Drostanolone—SHBG—obesity	0.00054	0.0561	CrCbGaD
Oxandrolone—Insomnia—Bupropion—obesity	0.000535	0.00608	CcSEcCtD
Oxandrolone—AR—Regulation of Androgen receptor activity—SIRT1—obesity	0.000534	0.00979	CbGpPWpGaD
Oxandrolone—Haemoglobin—Topiramate—obesity	0.000533	0.00606	CcSEcCtD
Oxandrolone—Haemorrhage—Topiramate—obesity	0.000531	0.00603	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—ESR1—obesity	0.000525	0.00962	CbGpPWpGaD
Oxandrolone—Danazol—CCL2—obesity	0.000512	0.0532	CrCbGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—FOXO1—obesity	0.000499	0.00915	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—PPARGC1B—obesity	0.000498	0.00913	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR3C1—obesity	0.000489	0.00896	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3R1—obesity	0.000485	0.00889	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptors—PPARG—obesity	0.000479	0.00878	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—NR3C1—obesity	0.000474	0.00869	CbGpPWpGaD
Oxandrolone—Drostanolone—AR—obesity	0.000473	0.0492	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF7L2—obesity	0.000469	0.00859	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—ESR1—obesity	0.000467	0.00856	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARA—obesity	0.000458	0.0084	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—HDAC8—obesity	0.000453	0.0083	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NCOA1—obesity	0.000435	0.00798	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—INS—obesity	0.000418	0.00766	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—ESR1—obesity	0.000415	0.00761	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO3—obesity	0.000414	0.00759	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—NCOA1—obesity	0.000404	0.0074	CbGpPWpGaD
Oxandrolone—Drostanolone—CYP19A1—obesity	0.000396	0.0412	CrCbGaD
Oxandrolone—Allylestrenol—ESR1—obesity	0.000392	0.0407	CrCbGaD
Oxandrolone—Testosterone Propionate—COMT—obesity	0.000387	0.0402	CrCbGaD
Oxandrolone—Trilostane—ESR1—obesity	0.000382	0.0397	CrCbGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—obesity	0.000379	0.00694	CbGpPWpGaD
Oxandrolone—Oedema—Topiramate—obesity	0.000377	0.00428	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—PRKAR2B—obesity	0.000369	0.00677	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—obesity	0.000365	0.00669	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CPT1A—obesity	0.000356	0.00653	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—obesity	0.000356	0.00652	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SIRT1—obesity	0.000353	0.00647	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GCK—obesity	0.000347	0.00637	CbGpPWpGaD
Oxandrolone—Insomnia—Topiramate—obesity	0.000341	0.00387	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—obesity	0.000338	0.00619	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TF—obesity	0.000331	0.00607	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—FOXO1—obesity	0.00033	0.00604	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CST3—obesity	0.000314	0.00575	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SLC6A4—obesity	0.000312	0.00571	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—SHBG—obesity	0.000305	0.0317	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NTRK2—obesity	0.000303	0.00556	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGFBP3—obesity	0.000295	0.00542	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IAPP—obesity	0.000294	0.00538	CbGpPWpGaD
Oxandrolone—Danazol—SHBG—obesity	0.000291	0.0303	CrCbGaD
Oxandrolone—Testosterone Propionate—AR—obesity	0.000289	0.03	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—obesity	0.000287	0.00525	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—ESR2—obesity	0.00028	0.00513	CbGpPWpGaD
Oxandrolone—Spironolactone—SHBG—obesity	0.000279	0.029	CrCbGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—obesity	0.000276	0.00506	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CAV1—obesity	0.000276	0.00506	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—obesity	0.000273	0.005	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—AR—obesity	0.000267	0.0278	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—STK11—obesity	0.000261	0.00478	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CYP19A1—obesity	0.000261	0.00478	CbGpPWpGaD
Oxandrolone—Norethindrone—SHBG—obesity	0.000259	0.0269	CrCbGaD
Oxandrolone—Danazol—AR—obesity	0.000256	0.0266	CrCbGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—STAT3—obesity	0.000248	0.00454	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—MAPK8—obesity	0.000246	0.00452	CbGpPWpGaD
Oxandrolone—Methyltestosterone—SHBG—obesity	0.000246	0.0256	CrCbGaD
Oxandrolone—Spironolactone—AR—obesity	0.000245	0.0254	CrCbGaD
Oxandrolone—AR—Gene Expression—APOBEC1—obesity	0.00024	0.00441	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARD—obesity	0.000239	0.00437	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR2—obesity	0.000238	0.00436	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—obesity	0.000236	0.00432	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—GNB3—obesity	0.000233	0.00427	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—PPARGC1A—obesity	0.000233	0.00427	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SIRT1—obesity	0.000231	0.00424	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—BDNF—obesity	0.000226	0.00415	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—obesity	0.000223	0.00409	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—obesity	0.000222	0.00407	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1I3—obesity	0.000217	0.00398	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR0B2—obesity	0.000217	0.00398	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STK11—obesity	0.000216	0.00396	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—FOXO1—obesity	0.000216	0.00396	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL10—obesity	0.000216	0.00396	CbGpPWpGaD
Oxandrolone—Methyltestosterone—AR—obesity	0.000216	0.0224	CrCbGaD
Oxandrolone—Danazol—CYP19A1—obesity	0.000214	0.0222	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RHOA—obesity	0.000211	0.00386	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PIK3R1—obesity	0.000209	0.00382	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—ESR1—obesity	0.000206	0.0214	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—NR3C1—obesity	0.0002	0.00366	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR1I2—obesity	0.000199	0.00364	CbGpPWpGaD
Oxandrolone—Danazol—ESR1—obesity	0.000197	0.0205	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—obesity	0.000192	0.00353	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—obesity	0.000192	0.00351	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HTR2A—obesity	0.000191	0.0035	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—obesity	0.000182	0.00334	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CTNNBL1—obesity	0.000182	0.00334	CbGpPWpGaD
Oxandrolone—Fluoxymesterone—NR3C1—obesity	0.000181	0.0188	CrCbGaD
Oxandrolone—Methyltestosterone—CYP19A1—obesity	0.000181	0.0188	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ESR1—obesity	0.000174	0.00319	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BAD—obesity	0.00017	0.00312	CbGpPWpGaD
Oxandrolone—Spironolactone—NR3C1—obesity	0.000166	0.0173	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—IRS1—obesity	0.000163	0.00298	CbGpPWpGaD
Oxandrolone—Progesterone—SHBG—obesity	0.000151	0.0157	CrCbGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—obesity	0.000151	0.00276	CbGpPWpGaD
Oxandrolone—Progesterone—SLC22A1—obesity	0.000149	0.0155	CrCbGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—obesity	0.000149	0.00273	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—STAT3—obesity	0.000149	0.00273	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—obesity	0.000144	0.00264	CbGpPWpGaD
Oxandrolone—Testosterone—SHBG—obesity	0.000143	0.0148	CrCbGaD
Oxandrolone—Testosterone—SLC22A1—obesity	0.000141	0.0146	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BAD—obesity	0.000141	0.00258	CbGpPWpGaD
Oxandrolone—Progesterone—AR—obesity	0.000132	0.0138	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BCL2—obesity	0.000132	0.00241	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—obesity	0.00013	0.00238	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MTOR—obesity	0.000126	0.00231	CbGpPWpGaD
Oxandrolone—Testosterone—AR—obesity	0.000125	0.013	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IGF1—obesity	0.000125	0.00229	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PARP1—obesity	0.000125	0.00229	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR2—obesity	0.000118	0.00217	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARD—obesity	0.000115	0.00211	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL1B—obesity	0.000113	0.00208	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BCL2—obesity	0.000109	0.002	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NCOA1—obesity	0.000109	0.002	CbGpPWpGaD
Oxandrolone—Testosterone—CYP19A1—obesity	0.000105	0.0109	CrCbGaD
Oxandrolone—AR—Gene Expression—NR1I3—obesity	0.000105	0.00192	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR0B2—obesity	0.000105	0.00192	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—obesity	0.000104	0.0019	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—obesity	0.000103	0.00189	CbGpPWpGaD
Oxandrolone—Progesterone—ESR1—obesity	0.000102	0.0106	CrCbGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—obesity	9.59e-05	0.00176	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR1I2—obesity	9.57e-05	0.00175	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—obesity	9.06e-05	0.00166	CbGpPWpGaD
Oxandrolone—Progesterone—NR3C1—obesity	8.98e-05	0.00934	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	8.83e-05	0.00162	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR3C1—obesity	8.44e-05	0.00155	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—obesity	8.22e-05	0.00151	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARA—obesity	7.91e-05	0.00145	CbGpPWpGaD
Oxandrolone—Norethindrone—ALB—obesity	7.8e-05	0.0081	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—obesity	7.5e-05	0.00138	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	7.49e-05	0.00137	CbGpPWpGaD
Oxandrolone—Methyltestosterone—ALB—obesity	7.4e-05	0.00769	CrCbGaD
Oxandrolone—AR—Generic Transcription Pathway—ESR1—obesity	7.17e-05	0.00131	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—obesity	6.99e-05	0.00128	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL6—obesity	6.63e-05	0.00122	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—obesity	6.54e-05	0.0012	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	6.37e-05	0.00117	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—obesity	6.28e-05	0.00115	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PARP1—obesity	6.01e-05	0.0011	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—SERPINE1—obesity	5.89e-05	0.00108	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR2—obesity	5.69e-05	0.00104	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NCOA1—obesity	5.24e-05	0.000961	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—obesity	5.2e-05	0.000954	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SIRT1—obesity	4.58e-05	0.00084	CbGpPWpGaD
Oxandrolone—Testosterone—ALB—obesity	4.29e-05	0.00446	CrCbGaD
Oxandrolone—AR—Gene Expression—NR3C1—obesity	4.06e-05	0.000745	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PRKCD—obesity	3.97e-05	0.000728	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARA—obesity	3.81e-05	0.000698	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—obesity	3.73e-05	0.000683	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—ESR1—obesity	3.45e-05	0.000633	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARG—obesity	3.15e-05	0.000577	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SERPINE1—obesity	2.84e-05	0.00052	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—obesity	1.79e-05	0.000329	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—obesity	1.24e-05	0.000228	CbGpPWpGaD
